GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genix Pharmaceuticals Corp (TSXV:GENX) » Definitions » Pretax Margin %

Genix Pharmaceuticals (TSXV:GENX) Pretax Margin % : % (As of Jan. 2025)


View and export this data going back to 1999. Start your Free Trial

What is Genix Pharmaceuticals Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Genix Pharmaceuticals's Pre-Tax Income for the three months ended in Jan. 2025 was C$-0.11 Mil. Genix Pharmaceuticals's Revenue for the three months ended in Jan. 2025 was C$0.00 Mil. Therefore, Genix Pharmaceuticals's pretax margin for the quarter that ended in Jan. 2025 was %.

The historical rank and industry rank for Genix Pharmaceuticals's Pretax Margin % or its related term are showing as below:

TSXV:GENX' s Pretax Margin % Range Over the Past 10 Years
Min: -36633.33   Med: -83.87   Max: -5.95
Current: -3025


TSXV:GENX's Pretax Margin % is ranked worse than
97.85% of 975 companies
in the Drug Manufacturers industry
Industry Median: 5.93 vs TSXV:GENX: -3025.00

Genix Pharmaceuticals Pretax Margin % Historical Data

The historical data trend for Genix Pharmaceuticals's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genix Pharmaceuticals Pretax Margin % Chart

Genix Pharmaceuticals Annual Data
Trend Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -36,633.33 -1,825.00

Genix Pharmaceuticals Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -2,866.67 -8,200.00 - -

Competitive Comparison of Genix Pharmaceuticals's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Genix Pharmaceuticals's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genix Pharmaceuticals's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genix Pharmaceuticals's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Genix Pharmaceuticals's Pretax Margin % falls into.


;
;

Genix Pharmaceuticals Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Genix Pharmaceuticals's Pretax Margin for the fiscal year that ended in Oct. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: Oct. 2024 )/Revenue (A: Oct. 2024 )
=-0.073/0.004
=-1,825.00 %

Genix Pharmaceuticals's Pretax Margin for the quarter that ended in Jan. 2025 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jan. 2025 )/Revenue (Q: Jan. 2025 )
=-0.107/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genix Pharmaceuticals  (TSXV:GENX) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Genix Pharmaceuticals Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Genix Pharmaceuticals's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Genix Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 1J8
Genix Pharmaceuticals Corp is a Canadian life sciences company focused on the research, development, manufacturing, sales, and distribution of novel, branded generic ophthalmic drugs, and ophthalmic OTC products. It operates as a formulator, manufacturer, licensor, and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals. Its ophthalmic products portfolio comprises different kinds of eye ointments (pending approval), and eye drops. Geographically, the company operates only in Canada.
Executives
Sina Pirooz Director
Paul Chow 10% Security Holder, Director
Jamie A. Lewin Director

Genix Pharmaceuticals Headlines

No Headlines